These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8811227)
1. Funding of coronary angioplasty in public hospitals. Batey RG Aust N Z J Med; 1996 Jun; 26(3):430. PubMed ID: 8811227 [No Abstract] [Full Text] [Related]
2. Funding of coronary angioplasty in public hospitals. Eccleston DS; Eisenberg MJ Aust N Z J Med; 1996 Jun; 26(3):430-1. PubMed ID: 8811228 [No Abstract] [Full Text] [Related]
3. Funding of coronary angioplasty and coronary stenting in public hospitals. Harper RW Aust N Z J Med; 1996 Feb; 26(1):3-4. PubMed ID: 8775519 [No Abstract] [Full Text] [Related]
4. Costs, charges and revenues of elective coronary angioplasty and stenting: the public versus the private system. Harper RW; Sampson KD; See PL; Kealey JL; Meredith IT Med J Aust; 2000 Sep; 173(6):296-300. PubMed ID: 11061398 [TBL] [Abstract][Full Text] [Related]
5. Economic impact of angioplasty salvage techniques, with an emphasis on coronary stents: a method incorporating costs, revenues, clinical effectiveness and payer mix. Vaitkus PT; Witmer WT; Brandenburg RG; Wells SK; Zehnacker JB J Am Coll Cardiol; 1997 Oct; 30(4):894-900. PubMed ID: 9316515 [TBL] [Abstract][Full Text] [Related]
6. The euros and sense of stents: do we get value for money? Annemans L J Cardiovasc Med (Hagerstown); 2011 Dec; 12(12):878-82. PubMed ID: 22025203 [No Abstract] [Full Text] [Related]
7. [Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA]. Chino M; Sasaki T Nihon Rinsho; 2003 Apr; 61 Suppl 4():632-7. PubMed ID: 12735043 [No Abstract] [Full Text] [Related]
8. Should use of intracoronary stents during percutaneous revascularisation be restricted? Palmer N; Fort S; Starkey I; Shaw T; Northridge D Lancet; 1998 Feb; 351(9100):416-7. PubMed ID: 9482299 [No Abstract] [Full Text] [Related]
9. How viable is Victoria's funding policy? Braithwaite J Aust J Public Health; 1994 Dec; 18(4):355-7. PubMed ID: 7718647 [No Abstract] [Full Text] [Related]
10. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Coronary stents: an industry perspective. Marshall PR Am Heart J; 1999 May; 137(5):S138-41. PubMed ID: 10220617 [No Abstract] [Full Text] [Related]
11. The financial impact of an endoluminal stenting procedure. Mackey LG; Merriel RB; Myers KA Aust Health Rev; 1998; 21(1):130-8. PubMed ID: 10181667 [TBL] [Abstract][Full Text] [Related]
12. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Coronary stents: a health system perspective. Ahmad M Am Heart J; 1999 May; 137(5):S142-4. PubMed ID: 10220618 [No Abstract] [Full Text] [Related]
13. To stent or not to stent?: A sterile debate. Westaby S; Channon K; Banning A BMJ; 2007 Jul; 335(7611):111. PubMed ID: 17641307 [No Abstract] [Full Text] [Related]
14. Adopting surgical innovation within activity-based funding for public hospitals. Coory MD; Thompson BS; Jordan SJ Med J Aust; 2013 Feb; 198(2):88. PubMed ID: 23373497 [No Abstract] [Full Text] [Related]
15. Cost-effective analysis of primary infarct-artery stenting versus optimal primary angioplasty (the Florence Randomized Elective Stenting in Acute Coronary Occlusions [FRESCO] trial). Antoniucci D; Valenti R; Moschi G; Santoro GM; Bolognese L; Trapani M; Fazzini PF Am J Cardiol; 2000 May; 85(10):1247-9. PubMed ID: 10802011 [No Abstract] [Full Text] [Related]
17. Dear Minister, please save me from case-mix funding. An open letter to the Minister for Community Services and Health. Stoelwinder JU Aust Health Rev; 1990; 13(4):318-25. PubMed ID: 10117327 [No Abstract] [Full Text] [Related]